Camlin Fine Sciences Limited
Franklin Templeton Mutual Fund, which previously held 1.69 percent of Camlin Fine Sciences Limited, is no longer listed among its major shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting requirement.
A specialty chemicals manufacturer based in India, Camlin Fine Sciences produces high-performance chemical products for diverse industrial applications including pharmaceuticals, agrochemicals, and performance chemicals. The company serves customers across domestic and international markets through its integrated manufacturing facilities. Its focus on research-driven product development and technical expertise in specialty chemical synthesis distinguishes it within the competitive chemicals sector.
Indian arm of Franklin Templeton Investments, a global AMC with over USD 1.5 trillion in assets worldwide. Manages over Rs 1.2 lakh crore in India. Navigated a significant setback when six debt schemes were wound up in April 2020 due to illiquid credit exposure, with full investor capital recovered by 2022. Equity franchise led by CIO Anand Radhakrishnan has maintained consistent performance through the volatility.